| Authors: |
Sedrak MS; Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. Electronic address: msedrak@mednet.ucla.edu., Lee MK; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., Ji J; Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, USA., Satele DV; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Poorvu PD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., O'Connor T; Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Williams GR; Department of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Hopkins JO; SCOR/NCORP/Novant Health Cancer Institute, Winston-Salem, NC, USA., Muss HB; Department of Medicine, University of North Carolina, Chapel Hill, NC, USA., Cohen HJ; Department of Medicine, Duke University School Medical Center, Durham, NC, USA., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Carey LA; Department of Medicine, University of North Carolina, Chapel Hill, NC, USA., Chow SL; Alliance Protocol Operations Office, Chicago, IL, USA., Subbiah N; Alliance Protocol Operations Office, Chicago, IL, USA., Le-Rademacher J; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., Jatoi A; Department of Oncology, Mayo Clinic, Rochester, MN, USA. |
